{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:04:29Z","timestamp":1773983069140,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-025-00773-w","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:49:25Z","timestamp":1762962565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effectiveness of unfractionated heparin vs. low molecular weight (Enoxaparin) in Acute Respiratory Distress Syndrom (ARDS) and metabolic dysfunction: an old drug for new indication!"],"prefix":"10.1186","volume":"26","author":[{"given":"Shabnam","family":"Delasoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Mojtahedzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbass","family":"Kebriaeezadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samin","family":"Sabzevari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Sabzevari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"11","key":"773_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"773_CR2","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","volume":"46","author":"C Fleischmann-Struzek","year":"2020","unstructured":"Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46:1552\u201362.","journal-title":"Intensive Care Med"},{"key":"773_CR3","first-page":"67","volume-title":"Multiorgan system failure in sepsis","author":"MA Gonzalez","year":"2018","unstructured":"Gonzalez MA, Ochoa CD. Multiorgan system failure in sepsis. Sepsis: Springer; 2018. pp. 67\u201371."},{"key":"773_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jss.2019.01.020","volume":"238","author":"Y Liu","year":"2019","unstructured":"Liu Y, Mu S, Li X, Liang Y, Wang L, Ma X. Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J Surg Res. 2019;238:175\u201385.","journal-title":"J Surg Res"},{"key":"773_CR5","first-page":"341e349","volume":"30","author":"T Miyashita","year":"2016","unstructured":"Miyashita T, Ahmed AK, Nakanuma S, et al. A three-phase approach for the early identification of acute lung injury induced by severe sepsis. Vivo. 2016;30:341e349.","journal-title":"Vivo"},{"issue":"11","key":"773_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112412","volume":"10","author":"W Wasyluk","year":"2021","unstructured":"Wasyluk W, Zwolak A. Metabolic alterations in sepsis. J Clin Med. 2021;10(11):2412.","journal-title":"J Clin Med"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccm.2016.01.011","volume":"37","author":"JA Englert","year":"2016","unstructured":"Englert JA, Rogers AJ. Metabolism. Metabolomics, and nutritional support of patients with sepsis. Clin Chest Med. 2016;37:321\u201331.","journal-title":"Clin Chest Med"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.thromres.2020.06.007","volume":"193","author":"L Li","year":"2020","unstructured":"Li L, Yu S, Fu S, Ma X, Li X. Unfractionated heparin inhibits histone\u2013mediated coagulation activation and thrombosis in mice. Thromb Res. 2020;193:122\u20139.","journal-title":"Thromb Res"},{"issue":"1","key":"773_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-020-0238-7","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Li L, Shi Y, Yu S, Ma X. Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells. J Inflamm. 2020;17(1):1\u20139.","journal-title":"J Inflamm"},{"issue":"4","key":"773_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/SHK.0000000000001900","volume":"57","author":"K Katsaros","year":"2022","unstructured":"Katsaros K, Renieris G, Safarika A, Adami EM, Gkavogianni T, Giannikopoulos G, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study. Shock. 2022;57(4):518\u201325.","journal-title":"Shock"},{"issue":"3","key":"773_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SHK.0000000000000862","volume":"48","author":"J Fisher","year":"2017","unstructured":"Fisher J, Russell JA, Bentzer P, Parsons D, Secchia S, M\u00f6rgelin M, et al. Heparin-binding protein (HBP): a causative marker and potential target for heparin treatment of human sepsis-induced acute kidney injury. Shock. 2017;48(3):313\u201320.","journal-title":"Shock"},{"issue":"3","key":"773_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/bjh.14885","volume":"179","author":"X Li","year":"2017","unstructured":"Li X, Ma X. The role of heparin in sepsis: much more than just an anticoagulant. Br J Haematol. 2017;179(3):389\u201398.","journal-title":"Br J Haematol"},{"issue":"2","key":"773_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3892\/etm.2016.3372","volume":"12","author":"F Jing","year":"2016","unstructured":"Jing F, Li M, Ren H, Zhang J, Yao Q, Chu Y, et al. Effects of Atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary pathophysiology of rats with sepsis. Exp Ther Med. 2016;12(2):1048\u201354.","journal-title":"Exp Ther Med"},{"issue":"2","key":"773_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11303","volume":"16","author":"YC Yeh","year":"2012","unstructured":"Yeh YC, Wang MJ, Lin CP, Fan SZ, Tsai JC, Sun WZ, Ko WJ. Enoxaparin sodium prevents intestinal microcirculatory dysfunction in endotoxemic rats. Crit Care. 2012;16(2):1\u20130.","journal-title":"Crit Care"},{"key":"773_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.lfs.2018.11.010","volume":"215","author":"AA Shalmani","year":"2018","unstructured":"Shalmani AA, Ghahremani MH, Jeivad F, Shadboorestan A, Hassanzadeh G, Beh-Pajooh A, et al. Monomethyl fumarate alleviates sepsis-induced hepatic dysfunction by regulating TLR-4\/NF-\u03baB signalling pathway. Life Sci. 2018;215:152\u20138.","journal-title":"Life Sci"},{"key":"773_CR16","unstructured":"Pirahanchi Y, Anoruo M, Sharma S. Biochemistry, lipoprotein lipase. StatPearls. 2021."},{"issue":"10","key":"773_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0018578717725168","volume":"52","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Finlay L. Treatment of hypertriglyceridemia-induced acute pancreatitis with insulin, heparin, and gemfibrozil: a case series. Hosp Pharm. 2017;52(10):675\u20138.","journal-title":"Hosp Pharm"},{"key":"773_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.615333","volume":"8","author":"HA Braz-de-Melo","year":"2021","unstructured":"Braz-de-Melo HA, Faria SS, Pasquarelli-do-Nascimento G, Santos ID, Kobinger GP, Magalh\u00e3es KG. The use of the anticoagulant heparin and corticosteroid dexamethasone as prominent treatments for COVID-19. Front Med. 2021;8:615333.","journal-title":"Front Med"},{"issue":"5","key":"773_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126763","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD, Stewart N, Horne J, Peterson GM, Gueven N, Sohal SS, et al. In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of Enoxaparin. PLoS ONE. 2015;10(5):e0126763.","journal-title":"PLoS ONE"},{"issue":"1","key":"773_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/ajrccm.165.1.2010084","volume":"165","author":"R Suzuki","year":"2002","unstructured":"Suzuki R, Freed AN. Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. Am J Respir Crit Care Med. 2002;165(1):27\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"773_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/SHK.0b013e31822798c1","volume":"36","author":"J Walker","year":"2011","unstructured":"Walker J, Dichter E, Lacorte G, Kerner D, Spur B, Rodriguez A, et al. Lipoxin A4 increases survival by decreasing systemic inflammation and bacterial load in sepsis. Shock. 2011;36(4):410\u20136.","journal-title":"Shock"},{"key":"773_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650184","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Wan D, Luo X, Song T, Wang Y, Yu Q, et al. Circulating histones in sepsis: potential outcome predictors and therapeutic targets. Front Immunol. 2021;12:650184.","journal-title":"Front Immunol"},{"issue":"5","key":"773_CR23","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.thromres.2012.03.003","volume":"129","author":"X Li","year":"2012","unstructured":"Li X, Zheng Z, Mao Y, Ma X. Unfractionated heparin promotes LPS-induced endothelial barrier dysfunction: a preliminary study on the roles of angiopoietin\/Tie2 axis. Thromb Res. 2012;129(5):e223-8.","journal-title":"Thromb Res"},{"issue":"3","key":"773_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031823","volume":"23","author":"M Ebeyer-Masotta","year":"2022","unstructured":"Ebeyer-Masotta M, Eichhorn T, Weiss R, Semak V, Laukov\u00e1 L, Fischer MB, et al. Heparin-functionalized adsorbents eliminate central effectors of immunothrombosis, including platelet factor 4, high-mobility group box 1 protein and histones. Int J Mol Sci. 2022;23(3):1823.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"773_CR25","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.2337\/db06-0221","volume":"55","author":"KM Myint","year":"2006","unstructured":"Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low\u2013molecular weight heparin. Diabetes. 2006;55(9):2510\u201322.","journal-title":"Diabetes"},{"issue":"1","key":"773_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5535562","volume":"2021","author":"S Kasirzadeh","year":"2021","unstructured":"Kasirzadeh S, Ghahremani MH, Setayesh N, Jeivad F, Shadboorestan A, Taheri A, et al. \u03b2-sitosterol alters the inflammatory response in CLP rat model of sepsis by modulation of NF\u03baB signaling. BioMed Res Int. 2021;2021(1):5535562.","journal-title":"BioMed Res Int"},{"key":"773_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40199-016-0154-9","volume":"24","author":"M Aliomrani","year":"2016","unstructured":"Aliomrani M, Sepand MR, Mirzaei HR, Kazemi AR, Nekonam S, Sabzevari O. Effects of phloretin on oxidative and inflammatory reaction in rat model of cecal ligation and puncture induced sepsis. DARU J Pharm Sci. 2016;24:1\u20138.","journal-title":"DARU J Pharm Sci"},{"key":"773_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1537680","volume":"12","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhou W, Xu W, Lv XP, Wang FF, Wang XB, et al. The value of heparin-binding protein in bronchoalveolar lavage fluid in acute respiratory distress syndrome. Front Med. 2025;12:1537680.","journal-title":"Front Med"},{"key":"773_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-025-00727-x","volume":"13","author":"D Cosgrave","year":"2025","unstructured":"Cosgrave D, McNicholas B, Hanley C, Sheehan JR, Calpin P, Kernan M, et al. Can nebulised heparin reduce acute lung injury in patients with SARS\u2013CoV\u20132 requiring advanced respiratory support in Ireland: the CHARTER\u2013Ireland phase Ib\/IIa, randomised, parallel-group, open-label study. Intensive Care Med Exp. 2025;13:15.","journal-title":"Intensive Care Med Exp"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00773-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-025-00773-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-025-00773-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:49:26Z","timestamp":1762962566000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-025-00773-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1186\/s12865-025-00773-w","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal-related operations were conducted according to NIH guidelines for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85\u2009\u2212\u200923, revised 1996). Also, the operations were authorized by the TUMS Ethical Committee for Animal Experimentation (code: IR.TUMS.MEDICINE.REC.1400.040).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}